I think that part of the issue is that THC containing products tend to have much worse side-effects so are less likely to be licensed by companies
-
-
With >15000 articles including double blind studies in existence many done in Israel at what point will you believe it has the research needed to say it works
1 reply 0 retweets 1 like -
Replying to @someguyhooper @braddybb
Bit of a straw man of my position. I am cautiously optimistic about the potential benefits in epilepsy treatment. Wrote about it herehttp://observer.com/2017/06/medical-marijuana-chemotherapy-epilepsy/ …
1 reply 0 retweets 0 likes -
The review you site in this article suggests no reliable conclusions can be drawn at present but more research is needed.
1 reply 0 retweets 0 likes -
Replying to @someguyhooper @braddybb
Pretty much. Firm conclusions about benefit are misleading, but harms have been quite robustly demonstrated. Hence my caution
2 replies 0 retweets 0 likes -
I think the epilepsy part of your article is misleading, costs/side effects of other medications are significant. On PBS you get given cheapest Benz variant.
1 reply 0 retweets 0 likes -
Maybe this is more a criticism of cost efficiency in the PBS, but the reality is that patients have to deal with these things outside of a simulation.
1 reply 0 retweets 0 likes
I'd never say that other epilepsy meds are perfect, just that cannabis is no different, really. It might work better for some, it might not help others, and some people will experience nasty side-effects
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.